Singapore Health News API

{
    "totalArticles": 43098,
    "articles": [
        {
            "id": "496bb18e482e9698091c37c6ebfa48b8",
            "title": "Tetrahydropalmatine Identified as Enhancer of CD8+ T Cell Activity and Inducer of Ferroptosis in Gastric Cancer Cells",
            "description": "Researchers have identified L-Tetrahydropalmatine (L-TH […]",
            "content": "L-Tetrahydropalmatine Identified as Enhancer of CD8+ T Cell Activity and Inducer of Ferroptosis in Gastric Cancer Cells\nResearchers have identified L-Tetrahydropalmatine (L-THP), a natural alkaloid compound, as having significant effects on gastric c... [1125 chars]",
            "url": "https://www.geneonline.com/l-tetrahydropalmatine-identified-as-enhancer-of-cd8-t-cell-activity-and-inducer-of-ferroptosis-in-gastric-cancer-cells/",
            "image": "https://www.geneonline.com/wp-content/uploads/EN_NEWSFLASH_5-1.png",
            "publishedAt": "2025-11-24T19:41:21Z",
            "lang": "en",
            "source": {
                "id": "e5376462a7128acdb762718aa2daf90e",
                "name": "geneonline.com",
                "url": "https://www.geneonline.com"
            }
        },
        {
            "id": "9e1ea6883f1ecc2d3a4b512cbc9babc3",
            "title": "Generation Platform to Crack the Toughest Challenge in Autoimmune and Allergy Drug Development: Multi",
            "description": "The newly upgraded HKEY-AIDMD 3.0 model library features nearly 300 autoimmune and allergy-related disease models. For multiple major indications, HKeyBio has established four-dimensional (4D) model pools that simulate clinical heterogeneity, providing a mechanism-driven model selection platform for evaluating multi-target combination therapies. The HKEY-AIDMD 3.0 omics database integrates spatiotemporal single-cell and spatial omics across various tissues […]",
            "content": "The newly upgraded HKEY-AIDMD 3.0 model library features nearly 300 autoimmune and allergy-related disease models. For multiple major indications, HKeyBio has established four-dimensional (4D) model pools that simulate clinical heterogeneity, providi... [5302 chars]",
            "url": "https://laotiantimes.com/2025/11/24/hkeybio-launches-the-hkey-aidmd-3-0-a-next-generation-platform-to-crack-the-toughest-challenge-in-autoimmune-and-allergy-drug-development-multi-target-combination-strategy-optimization/",
            "image": "https://laotiantimes.com/wp-content/uploads/2025/11/hkey_aidmd_3_0.jpg",
            "publishedAt": "2025-11-24T16:30:00Z",
            "lang": "en",
            "source": {
                "id": "2ea29d5e22ad4ce35ad897c616bb0406",
                "name": "Laotian Times",
                "url": "https://laotiantimes.com"
            }
        },
        {
            "id": "8b8e5815c98dbbca42bf9767d78430b1",
            "title": "Generation Platform to Crack the Toughest Challenge in Autoimmune and Allergy Drug Development: Multi",
            "description": "BOSTON and SUZHOU, China, Nov. 25, 2025 /PRNewswire/ -- HKeyBio, a global leading CRO specializing in preclinical and translational research for",
            "content": "The newly upgraded HKEY-AIDMD 3.0 model library features nearly 300 autoimmune and allergy-related disease models. For multiple major indications, HKeyBio has established four-dimensional (4D) model pools that simulate clinical heterogeneity, providi... [5565 chars]",
            "url": "https://www.thailand-business-news.com/pr-news/hkeybio-launches-the-hkey-aidmd-3-0-a-next-generation-platform-to-crack-the-toughest-challenge-in-autoimmune-and-allergy-drug-development-multi-target-combination-strategy-optimization",
            "image": "https://i0.wp.com/mma.prnasia.com/media2/2828480/HKEY_AIDMD_3_0.jpg?p=medium600&ssl=1",
            "publishedAt": "2025-11-24T16:30:00Z",
            "lang": "en",
            "source": {
                "id": "36b21a7b15c1cb7f5d1967271f6b2dee",
                "name": "Thailand Business News",
                "url": "https://www.thailand-business-news.com"
            }
        }
    ]
}